A detailed history of Strs Ohio transactions in Care Dx, Inc. stock. As of the latest transaction made, Strs Ohio holds 27,100 shares of CDNA stock, worth $584,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,100
Previous 40,000 32.25%
Holding current value
$584,005
Previous $621,000 36.23%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$14.41 - $33.99 $185,889 - $438,471
-12,900 Reduced 32.25%
27,100 $846,000
Q2 2024

Aug 05, 2024

SELL
$7.56 - $16.15 $83,916 - $179,264
-11,100 Reduced 21.72%
40,000 $621,000
Q1 2024

May 13, 2024

SELL
$7.96 - $12.37 $73,232 - $113,804
-9,200 Reduced 15.26%
51,100 $541,000
Q4 2023

Jan 30, 2024

BUY
$4.9 - $12.86 $116,620 - $306,068
23,800 Added 65.21%
60,300 $723,000
Q3 2023

Oct 26, 2023

BUY
$7.0 - $11.26 $22,400 - $36,032
3,200 Added 9.61%
36,500 $255,000
Q2 2023

Jul 31, 2023

BUY
$7.61 - $9.46 $19,786 - $24,596
2,600 Added 8.47%
33,300 $283,000
Q1 2023

Aug 02, 2023

SELL
$8.83 - $17.61 $22,958 - $45,786
-2,600 Reduced 7.81%
30,700 $280,000
Q2 2022

Jul 25, 2022

BUY
$20.49 - $39.72 $508,151 - $985,056
24,800 Added 420.34%
30,700 $659,000
Q3 2021

Oct 22, 2021

SELL
$59.15 - $91.99 $307,580 - $478,348
-5,200 Reduced 46.85%
5,900 $373,000
Q2 2021

Jul 26, 2021

BUY
$63.02 - $95.11 $12,604 - $19,022
200 Added 1.83%
11,100 $1.02 Million
Q4 2020

Jan 25, 2021

BUY
$41.43 - $77.09 $451,587 - $840,281
10,900 New
10,900 $789,000
Q4 2018

Jan 23, 2019

SELL
$19.89 - $30.02 $0 - $0
0 Closed
0 $0
Q3 2018

Oct 19, 2018

SELL
$12.1 - $28.85 $114,950 - $274,075
-9,500 Closed
0 $0
Q2 2018

Aug 06, 2018

BUY
$7.93 - $15.79 $75,335 - $150,005
9,500 New
9,500 $116,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.